Advertisement

Reactions Weekly

, Volume 1733, Issue 1, pp 114–114 | Cite as

Cobimetinib/vemurafenib

Photosensitivity and development of vemurafenib resistance in anaplastic ganglioglioma: case report
Case report
  • 13 Downloads

Reference

  1. Touat M, et al. Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma. Neurology 91: 523-525, No. 11, 11 Sep 2018. Available from: URL: http://doi.org/10.1212/WNL.0000000000006171 -FranceCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations